Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis by Hemilä, Harri & Chalker, Elizabeth
Hemilä and Chalker Journal of Intensive Care            (2020) 8:15 
https://doi.org/10.1186/s40560-020-0432-yRESEARCH Open AccessVitamin C may reduce the duration of
mechanical ventilation in critically ill
patients: a meta-regression analysis
Harri Hemilä1* and Elizabeth Chalker2Abstract
Background: Our recent meta-analysis indicated that vitamin C may shorten the length of ICU stay and the
duration of mechanical ventilation. Here we analyze modification of the vitamin C effect on ventilation time, by the
control group ventilation time (which we used as a proxy for severity of disease in the patients of each trial).
Methods: We searched MEDLINE, Scopus, and the Cochrane Central Register of Controlled Trials and reference lists
of relevant publications. We included controlled trials in which the administration of vitamin C was the only
difference between the study groups. We did not limit our search to randomized trials and did not require placebo
control. We included all doses and all durations of vitamin C administration. One author extracted study
characteristics and outcomes from the trial reports and entered the data in a spreadsheet. Both authors checked
the data entered against the original reports. We used meta-regression to examine whether the vitamin C effect on
ventilation time depends on the duration of ventilation in the control group.
Results: We identified nine potentially eligible trials, eight of which were included in the meta-analysis. We pooled
the results of the eight trials, including 685 patients in total, and found that vitamin C shortened the length of
mechanical ventilation on average by 14% (P = 0.00001). However, there was significant heterogeneity in the effect
of vitamin C between the trials. Heterogeneity was fully explained by the ventilation time in the untreated control
group. Vitamin C was most beneficial for patients with the longest ventilation, corresponding to the most severely
ill patients. In five trials including 471 patients requiring ventilation for over 10 h, a dosage of 1–6 g/day of vitamin
C shortened ventilation time on average by 25% (P < 0.0001).
Conclusions: We found strong evidence that vitamin C shortens the duration of mechanical ventilation, but the
magnitude of the effect seems to depend on the duration of ventilation in the untreated control group. The level
of baseline illness severity should be considered in further research. Different doses should be compared directly in
future trials.
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In controlled trials, vitamin C has improved endothelial
function, lowered blood pressure, increased left ventricu-
lar ejection fraction, decreased the incidence of atrial
fibrillation, decreased bronchoconstriction, prevented
pain, shortened the duration of colds, and decreased the
incidence of colds in physically stressed people, and it
may also have beneficial effects against pneumonia, see
reference [1].
The average person, in good health, maintains normal
plasma vitamin C levels with a daily intake of about 0.1
g/day. However, much higher doses, in the order of
grams per day, are needed for critically ill patients to
reach normal plasma vitamin C levels [2–5]. Without
supplementation, plasma vitamin C levels are particu-
larly low in critically ill patients [6–10], indicating that
the body may have a greater need for vitamin C when
under severe stress such as illness requiring intensive
care. It seems evident that there are gradual changes in
vitamin C metabolism according to the severity of
disease, in that the sicker a patient is, the greater the
consumption of vitamin C. This further suggests that
the sicker a patient is, the more they are likely to benefit
from additional vitamin C.
Given this background, we previously examined whether
vitamin C administration has an effect on practical out-
comes such as the length of ICU stay, without looking at
specific medical conditions. From the results of 12 trials
with 1766 patients, we calculated that vitamin C reduced
the length of ICU stay on average by 7.8% (P < 0.001) [1].
We also found that in trials in which the control
groups were ventilated for 24 h or more, vitamin C
shortened the duration of mechanical ventilation by 18%
(P = 0.001) [1]. However, vitamin C did not have an
effect on the duration of mechanical ventilation in trials
in which control groups were ventilated for less than 24
h, i.e., trials in patients with less severe illness.Fig. 1 Flow diagram showing the search terms. The searches were carried
included in our systematic review analysis [11–19] and eight of them wereIn this study, we hypothesize that there is a continuous
relationship between disease severity and the beneficial ef-
fect of vitamin C administration. We used meta-
regression to analyze the gradual relationship between the
effect of vitamin C in the treatment group and the dur-
ation of mechanical ventilation in untreated patients of
the control group, which we used as a proxy for the sever-
ity of the disease.
Methods
We included controlled trials that compared the length of
mechanical ventilation between vitamin C and control
groups. We included trials in which the administration of
vitamin C was the only difference between the study
groups; trials that administered other therapies as well as
vitamin C were included only if the other therapies were
the same for both trial groups. We did not limit our
search to randomized trials and did not require placebo
control. We included all doses and all durations of vitamin
C administration.
We searched MEDLINE, Scopus, and the Cochrane
Register on 13 Nov 2019 with the search phrases described
in Fig. 1. We had previously searched the same databases
for trials on vitamin C and ICU length of stay on 20 Jan
2019 [1]; from that search, we found trials that were not
well indexed and so not identified in our new search specif-
ically for trials on vitamin C and mechanical ventilation. Fi-
nally, we perused the reference lists of the selected trials
and relevant reviews, from which we discovered two more
trials. We identified nine trials satisfying our selection cri-
teria [11–19]. We did not include two further trials that re-
ported “ventilator-free days” since we were unable to
convert this to our outcome of interest, “duration of mech-
anical ventilation” [20, 21].
Tanaka et al. administered vitamin C continuously with
a dosage of 66mg/kg/h for the first 24 h only, with the re-
ported mean weight of patients being 57 kg [17]. Thus, weout on 13 Nov 2019. The searches identified nine trials that we
included in our meta-analysis [11–18]
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Tanaka trial. Zabet et al. administered 25mg/kg every 6 h,
but the mean weight was not reported [18]. Assuming a
mean weight of 60 kg, we estimated that the average dose
was 6 g/day in the Zabet trial. We use these estimates in
our text.
The outcome in this analysis is the length of mechan-
ical ventilation, which we analyzed on the relative scale.
The relative scale is usually more informative than the
absolute scale for the analysis of treatment effects on
continuous outcomes, in particular, for the analysis of
duration data [1, 22–24]. We used the ratio of means
(RoM) to estimate the effect of vitamin C, and the Tay-
lor series-based approach to calculate the log(RoM) [22].
We pooled the selected trials with the metagen function
of the meta package of the R statistical software [25–27],
using the inverse variance, fixed effect options. For meta-
regression, we used the metareg function of the meta
package. We used the χ2 test and the I2 statistic to assess
statistical heterogeneity among the trials in the meta-
analysis [28]. Values of I2 range from 0% to 100%. A value
close to 0% indicates very low-level heterogeneity. A value
of more than approximately 50% indicates moderate
heterogeneity, and a value over 75% indicates high-
level heterogeneity. Our calculations are described in
Additional files 1 and 2.
Results
Description of the included trials
Nine controlled trials have reported on vitamin C
administration and the length of mechanical ventilation
(Table 1; see Additional file 1: Table S1 for further detailsTable 1 Description of the included trials
Trial [ref.] N Setting Vitamin C
Route Dose (g/da
Bjordahl et al. [11] 185 Cardiac po 2
Amini et al. [12] 137 Cardiac po 3
Dehghani et al .[13] 100 Cardiac po 1
Habib et al. [14] 100 Sepsis iv 6
Safaei et al. [15] 58 Cardiac iv 2
Ebade et al. [16] 40 Cardiac iv 3
Tanaka et al. [17] 37 Burns iv 90*
Zabet et al. [18] 28 Sepsis iv 6*
Sadeghpour et al. [19]** 290 Cardiac po 1
The trials are listed by the number of patients (N). The mean age in the trials range
varied from 58% to 75%. Five trials were carried out in Iran [12, 13, 15, 18, 19], two
descriptions of the trials, see Additional file 1: Table S1. The Amini trial [12] results a
*Estimated vitamin C dose, see the “Methods” section
**Sadeghpour et al. [19] recruited 500 participants but reported the results for just
include this trial in our calculations, but we overlay the findings in Fig. 4
iv intravenous, po per oral, RoM ratio of means [22]: e.g., for the Bjordahl trial [11], R
in the vitamin C group was 14% shorter than in the placebo groupof the trials). The flow diagram of our search is shown in
Fig. 1.
The total number of patients was 975, with 810 pa-
tients in six cardiac surgery trials, 128 patients in two
sepsis trials, and 37 patients in one trial with burns pa-
tients (Table 1). Vitamin C was administered orally in
four trials and intravenously in five trials. The Tanaka
[17] trial administered 90 g/day, whereas the other seven
trials administered from 1 to 6 g/day. Safaei et al. [15]
and Tanaka et al. [17] administered vitamin C on a sin-
gle day only, six trials administered for 2–5 days [11–13,
16, 18, 19], and one administered “until ICU discharge”
for septic shock patients [14]. There is a 250-fold vari-
ation in the average length of mechanical ventilation in
the untreated groups from 2 h [16] to 511 h [17], which
reflects great variation in the severity of the baseline
medical condition (Table 1).
Six trials were randomized [11–13, 15, 18, 19], two
used alternative allocation [14, 17], and one did not de-
scribe the allocation method [16]. The reported baseline
variables for the treatment groups were balanced in all
trials (Additional file 1: Table S1). The risk of bias as-
sessment of the trials is shown in Fig. 2. Four trials used
an explicit placebo [11, 16, 18, 19]. The trial by Sadegh-
pour et al. [19] had a high dropout rate, with 500 partici-
pants recruited, but results were reported for just 290
participants [1]. We did not include this trial in our stat-
istical models, but the results are presented separately.
Results of the included trials
In our standard meta-analyses, we pooled the results of the
trials on the relative scale, calculating the ratio of meansLength of mechanical ventilation (hours) RoM
y) Vitamin C Control
Mean SD Mean SD
28.8 19.2 33.6 24.0 0.86
7.3 6.0 6.7 4.3 1.10
13.4 2.0 15.4 14.3 0.87
110 50 189 72 0.58
15.1 5.39 22.9 20.46 0.66
2.04 0.35 1.99 0.31 1.02
290 211 511 374 0.57
36.6 16.1 46.8 10.1 0.78
11.8 3.9 14.1 9.5 0.84
d from 42 to 64 years, with a median of 60 years. The proportion of males
in Egypt [14, 16], one in the USA [11], and one in Japan [17]. For detailed
re modified as described previously [1]
290 participants [1]. Because of the high dropout rate (42%), we did not
oM = 0.86, based on 28.8/33.6, and RoM = 0.86 indicates that ventilation time
Fig. 2 Risk of bias summary. Review authors’ judgments about each
risk of bias item for each included trial. A green plus sign (+) indicates
that there is no substantial concern for bias in the particular quality
item. A question mark (?) indicates that conclusions are unable to be
drawn regarding potential bias. A red minus sign (−) indicates that
there is an explicit concern regarding bias. In the Sadeghpour trial, the
dropout rate was very high (42%), justifying the minus sign [1]. The
reference numbers to the trials are shown in Table 1
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length of mechanical ventilation was 28.8 h in the vitamin
C group and 33.6 h in the placebo group, which corre-
sponds to RoM= 0.86 (28.8/33.6) (Table 1). This represents
a 14% shorter ventilation time in the vitamin C group.Over the eight included trials with 685 patients in
total, vitamin C shortened the length of mechanical ven-
tilation on average by 14% (P = 10−5) (Fig. 3). However,
there was highly significant heterogeneity in the vitamin
C effect between the trials with I2 = 83% (P = 4.8 × 10−7).
This indicates that the calculated average effect of 14% is
not consistent over all the included trials.
In a meta-regression analysis, we found that the het-
erogeneity between the trials was explained by the length
of mechanical ventilation in the untreated control group
(Fig. 4). The evidence for modification of the vitamin C
effect by the untreated ventilation time was very strong
(P = 10−7). There is little residual heterogeneity around
the regression line with I2 = 12% (P = 0.3), which indi-
cates that the meta-regression in Fig. 4 much better cap-
tures the findings of the trials compared with the
standard meta-analysis shown in Fig. 3. The confidence
intervals of all included trials are consistent with the re-
gression line in Fig. 4. The Habib [14] trial contributed
considerable weight to the effect of vitamin C in Fig. 4.
However, even if both the Habib [14] and Tanaka [17]
trials are excluded, there is strong evidence from the six
remaining trials that the effect of vitamin C is modified
by the ventilation time in the untreated control group
(P = 0.004) (see Additional file 1).
Figure 4 indicates that no meaningful benefit from
vitamin C is expected for patients whose ventilation time
is shorter than 10 h. On the other hand, the regression
line in Fig. 4 predicts that for patients ventilated for 100
h, vitamin C reduces the ventilation time on average by
31% (RoM = 0.69). Three trials administered vitamin C
orally and five intravenously, but both methods are con-
sistent with the single regression line in Fig. 4.
Tanaka et al. [17] used by far the highest dose of vita-
min C, 90 g/day. Figure 4 indicates that the substantial
benefit observed in that trial may be explained by the
particularly sick patients with burns requiring very long
ventilation, rather than by the very high vitamin C dose.
We found that vitamin C shortened the length of venti-
lation on average by 25% (P = 10−10) when the Tanaka
trial was excluded and the analysis was restricted to the
five trials with dosage from 1 to 6 g/day for patients ven-
tilated for over 10 h [11, 13–15, 18].
The Sadeghpour trial [19] is not included in our statis-
tical models because of the high dropout rate, but the
results are shown in Fig. 4 by the dashed line and they
are consistent with the findings of the other trials.
Secondary analysis of vitamin C and E combination trials
Our meta-regression analysis above was restricted to
studies in which vitamin C was administered as the
only difference between the study groups. We did not
carry out a systematic search for trials on the com-
bination of vitamins C and E, but in our search for
Fig. 3 Effect of vitamin C on the duration of ventilation. The horizontal lines indicate the 95% CI for the vitamin C effect and the blue squares in
the middle of the horizontal lines indicate the point estimate of the effect in the particular trial. The red diamond shape indicates the pooled
effect and its 95% CI. The Sadeghpour trial [19] is not included in the meta-analysis, since the dropout rate was high (42%) [1]. RoM ratio of
means [22]
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istered vitamins C and E together to critically ill pa-
tients [29–31]. Given that our search for vitamin C
also identifies any combinations of vitamins C and E,
it is unlikely that there are many more combination
trials. As a secondary analysis, we compared the find-
ings of the three vitamin C and E trials with our
meta-regression model based on the eight trials using
vitamin C alone (Fig. 5).Fig. 4 Effect of vitamin C on the duration of ventilation by the duration of
the null effect. The diagonal line shows the meta-regression line for the eig
was administered orally (open circles) or intravenously (filled circles). The re
of ventilation). For example, for a ventilation time of 100 h (log10[100] = 2),
RoM = 0.69, i.e., a 31% shorter ventilation time. The Sadeghpour trial [19] is
however, it is overlaid here for information. For calculations, see AdditionalNathens et al. administered 1 g/day vitamin C intra-
venously and 1000 IU/day vitamin E enterally [29]. The
duration of mechanical ventilation in the control group
was 110 h, for which our model predicts a 32% decrease
in the vitamin C group. The observed decrease in the vi-
tamins C and E group was 20% (95% CI 13% to 26%).
Crimi et al. administered 0.5 g/day vitamin C and 400
IU/day vitamin E enterally [30]. Ventilation time in the
control group was 213 h, for which our model predicts aventilation in the control group. The horizontal dashed line indicates
ht trials, with P = 10−7 for the test that the slope is not null. Vitamin C
gression line follows the formula ln(RoM) = 0.150–0.263 × log10(length
the formula gives ln(RoM) = − 0.377, and predicts a vitamin C effect of
not included in the statistical model, since the dropout rate was high;
file 2. RoM ratio of means [22]
Fig. 5 Effect of the combination of vitamins C and E on the duration of ventilation by the duration of ventilation in the control group. The
diagonal line shows the meta-regression line based on the vitamin C alone trials from Fig. 4. The horizontal dashed line indicates the null effect.
The results of the three trials [29–31] and their 95% CIs are shown. For calculations, see Additional file 2. RoM ratio of means [22]
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crease was 30% (95% CI 0% to 61%).
Howe et al. administered 1 g/day vitamin C and 1000
IU/day vitamin E enterally [31]. Ventilation time in the
control group was 456 h, and our model predicts a 42%
decrease in the vitamin C group. The observed decrease
was 47% (95% CI 7% to 87%). In all three vitamin C
and E trials, the observed effect of treatment was quite
close to the effect predicted by the trials using only
vitamin C (Fig. 5; see Additional files 1 and 2 for the
calculations).
Discussion
There is significant variation in the severity of disease in
patients who are mechanically ventilated. One measure
of severity is the mechanical ventilation time required by
the patient, which we used as a proxy for severity. In this
study, we found that the duration of ventilation in the
untreated control group explained most of the variation
in the reported effects of vitamin C on the mechanical
ventilation time. In the standard meta-analysis, there is
high-level heterogeneity with I2 = 83% (Fig. 3), whereas
in the meta-regression of the vitamin C effect by the
control group duration of ventilation, the residual het-
erogeneity is small with I2 = 12% (Fig. 4).
Some of the included trials examined elective surgical
patients. These patients are not usually critically ill; how-
ever, as a result of their surgery, they are routinely venti-
lated in the ICU for a period of time. In the meta-
regression, such patients are located on the left-hand
side of Fig. 4 which means that the analysis takes into
account the low level of illness severity. In contrast, theinclusion of patients with less severe disease in the
standard meta-analysis decreases the average effect of
vitamin C, so that the greater effect on the sicker pa-
tients is masked (Fig. 3).
The substantial benefit observed in the Tanaka [17]
trial seems to be explained by the particularly long
mechanical ventilation in the untreated control patients
(which reflects the greater illness severity), rather than
the particularly high vitamin C dosage of 90 g/day in that
trial. All the other trials used 6 g/day or less, but there is
no evidence that the benefit was less than in the Tanaka
trial when taking into account the ventilation time in the
untreated control group (Fig. 4). There are a few reports
of deaths caused by intravenous vitamin C in doses of
80 to 224 g/day [32, 33]. Therefore, the interpretation
that the benefit in the Tanaka trial may be caused by the
type of patients and not by the very high vitamin C dose
is important for planning further trials.
Our previous analysis of the length of ICU stay also
found that the effect of vitamin C appeared greater for
the sicker patients. The length of ICU stay was reduced
by 10.1% (P = 0.0001) in patients who required an ICU
stay of 3 days or longer, but by just 5.7% (P = 0.03) in
those who needed only 1–2 days in the ICU [1].
There are also other findings that are consistent with
vitamin C having a greater effect on patients with more
severe medical conditions. A meta-analysis of vitamin C
effect on exercise-induced bronchoconstriction found
that vitamin C halved FEV1 decline caused by exercise
[34]. The constant relative effect indicates that the abso-
lute effect was greatest for patients who had the greatest
bronchoconstriction in the exercise test. Finally, a trial
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dilatory effect of vitamin C was most beneficial for those
with the greatest bronchial hypersensitivity to histamine
[35, 36].
There is much evidence indicating that vitamins C and
E have an interaction in vitro and in vivo [37–41], and
three trials have examined the effect of the combination
of vitamins C and E on the duration of mechanical ven-
tilation [29–31]. The reported effects from the three tri-
als are largely consistent with the meta-regression model
based on the eight trials using vitamin C alone (Fig. 5),
though the confidence interval of the Nathens et al. trial
does not cross the regression line. Thus, the statistically
significant benefit observed in each of these three trials
might be explained by the long ventilation time in the
control groups, indicating greater severity of illness in
the patients, rather than by the addition of vitamin E to
the intervention. To test the possible additional benefit
of vitamin E over vitamin C would require 2 × 2 factorial
trials.
Although our meta-regression analysis by the ventila-
tion time in the control group explains the heterogeneity
in the published trials, it seems evident that other vari-
ables influence the effects of vitamin C. For example,
there are indications that treatment effects can differ be-
tween less and more developed countries. Panagiotou
et al. identified several studies that reported greater
treatment effects in less developed countries than in
more developed countries [42]. Although methodo-
logical variations may explain some of the differences,
there can also be genuine treatment differences between
substantially different cultures, since wealth is strongly
correlated with life-style factors including nutrition and
with differences in hospital treatments. Previously,
vitamin C was found to prevent post-operative atrial fib-
rillation in non-US trials, but not in US-based trials [43],
which may also indicate that the effects of vitamin C can
depend on cultural context. Thus, although the fit of the
meta-regression line in Fig. 4 is good, the findings should
not be extrapolated directly to other contexts.
Two recent meta-analyses concluded that vitamin C is
not beneficial for critically ill patients [44, 45], whereas a
third concluded that vitamin C was beneficial for sepsis
patients [46]. However, all three meta-analyses included
studies that administered vitamin C in combination with
numerous other substances, such as vitamins A, B, and
E, selenium, and zinc [47–49]. Such trials do not test the
specific effect of vitamin C. The other substances can
have negative or positive effects, and they can also mod-
ify the effect of vitamin C. The three meta-analyses also
had statistical shortcomings [47–49]. Our current meta-
analysis was restricted to trials that tested vitamin C
alone. A fourth recent meta-analysis concluded that vita-
min C shortens ventilation time in cardiac surgerypatients [50]; however, the study was shown to contain
several substantial statistical errors [51].
In systematic reviews, one potential concern is publi-
cation bias, in that negative trials may remain unpub-
lished. However, publication bias cannot realistically
generate the close association shown in Fig. 4. To
explain this association by publication bias would re-
quire that positive studies with less ill patients remain
unpublished, and negative studies with severely ill pa-
tients also remain unpublished. Five trials did not use an
explicit placebo [12–15, 17], but we do not consider that
the lack of placebo undermines the validity of those
trials, since ICU patients receive numerous treatments
and it is unlikely that one additional tablet or infusion
would cause a substantial placebo effect for ventilated
patients. The lack of a placebo may cause bias in research
on subjective outcomes, but less so on objective outcomes
[52]. Thus, it is unlikely to bias studies with outcomes
such as the duration of mechanical ventilation.Conclusions
It may not be worthwhile to carry out further research
on the effects of vitamin C on mechanical ventilation for
patient groups that require on average less than 10 h of
ventilation. The level of sickness severity should be taken
into account in future studies, for example, by evaluating
prognostic scores at the start of the trial. Our analysis
did not find differences between oral and intravenous
vitamin C, but oral administration is rarely an option for
the sickest patients, for whom the effects of vitamin C
appear greatest. Our analysis is not informative about
the optimal dosage of vitamin C. Future trials should
directly compare different dosage levels.Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40560-020-0432-y.
Additional file 1 Calculations; Table S1. Detailed description of the
included trials.
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